Kashyap Tele-Medicines Ltd - 531960 - Statement Of Investor Complaints For The Quarter Ended June 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Prerna KakkarDesignation :- Company Secretary and Compliance Officer Kashyap Tele-Medicines Ltd - 531960 - Shareholding for the Period Ended June 30, 2020
Kashyap Tele-Medicines Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2020. For more details, kindly Click here Kashyap Tele-Medicines Ltd - 531960 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
With reference to above, we hereby enclose the confirmation certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th June, 2020 received from Link Intime India Private Limited, Registrar and Share Transfer Agent of the Company for your reference. We request you to kindly take this on your record and oblige. Kashyap Tele-Medicines Ltd - 531960 - Disclosure Of Material Impact Of Covid-19 Pandemic
Pursuant to SEBI Circular No. SEBI/HO/CFD/CMD1/CIR/P/2020/84 dated 20th May, 2020 regarding advisory on disclosure of material impact of CoVID-19 Pandemic on listed entities under SEBI (LODR) Regulations, 2015 and further pursuant to Schedule III, Part A, Para B of Regulation 30 of SEBI (LODR) Regulations, 2015, the Company hereby submits the material impact of CoVID-19 Pandemic on the business and operations of the Company. Kashyap Tele-Medicines Ltd - 531960 - Format of Initial Disclosure to be made by an entity identified as a Large Corporate
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayKashyap Tele-Medicines Ltd 2CINL29110MH1995PLC085738 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: PRERNA KAKKAR Designation: Company Secretary EmailId: investor.relations@jindalonline.com Name of the Chief Financial Officer: RAGHAV AGRAWAL Designation: CFO and Director EmailId: investor.relations@jindalonline.com Date: 30/06/2020 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. Kashyap Tele-Medicines Ltd - 531960 - Non-Applicability Of Annual Secretarial Compliance Report Under Regulation-24A Of SEBI (Listing Obligations And Disclosure Requirements) (Amendment) Regulations, 2018 For The Year Ended 31St March, 2020.
With reference to the above mentioned subject and pursuant to SEBI Circular No: CIR/CFD/CMD1/27/2019 Dated 8th February, 2019 and under Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with BSE Circular no. LIST/COMP/10/2019-20 dated 9th May, 2019, filing of Annual Secretarial Compliance Report is not applicable to the Company due to reason that the Company is claiming the exemption under Regulation 15(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Kashyap Tele-Medicines Ltd - 531960 - Submission Of Audited Financial Results Of The Company And Auditor Report For The Quarter And Year Ended 31St March, 2020
With reference to above, we are pleased to submit herewith, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Audited Financial Results of the Company for the quarter and year ended 31st March, 2020, prepared in accordance with Companies (Indian Accounting Standards) Rules, 2015 (IND-AS), as reviewed by the Audit Committee and subsequently approved by the Board of Directors of the Company at their respective in meeting held on 26th June, 2020. Also please find enclosed herewith the Auditor's Report of the said Audited Financial Results of the Company for the quarter and year ended 31st March, 2020 as received from the Auditors of the Company. Kashyap Tele-Medicines Ltd - 531960 - Outcome Of Board Meeting Held On 26Th June, 2020 As Per Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
With reference to above and as per intimation given for meeting of the Board of Directors, we are pleased to inform that above referred meeting was held on 26th June, 2020 and Board of Directors has considered and approved, inter alia: 1. Audited Financial Results of the Company for the quarter and year ended 31st March, 2020, along with the reports of Auditors thereon pursuant to Regulation 33 of the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015. Further note that the Statutory Auditor of the Company have issued audit report with unmodified opinion in this regards; Kashyap Tele-Medicines Ltd - 531960 - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Kashyap Tele-Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/06/2020 ,inter alia, to consider and approve the Audited Financial Results for quarter and year ended 31st March, 2020 as per Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and to transact all such other businesses as per the agenda items of the Meeting.